ARCHIVES

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

This article is from The Cancer Letter archive.

Vol. 08 No. 13 | March 26, 1982

Download PDF Visit The Full Archive

Related Articles

NCI Communications Office to contract Media Campaigns

October 22, 1993

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977